<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) display both haematological and biological <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> with variable <z:mpath ids='MPATH_336'>leukaemia</z:mpath> potential </plain></SENT>
<SENT sid="1" pm="."><plain>MicroRNAs play an important role in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppression and the regulation of self-renewal and differentiation of haematopoietic progenitors </plain></SENT>
<SENT sid="2" pm="."><plain>Using a microarray platform, we evaluated microRNA expression from 44 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 17 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="3" pm="."><plain>We identified a thirteen microRNA signature with statistically significant differential expression between <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> specimens (P &lt; 0·01), including down-regulation of members of the <z:mpath ids='MPATH_336'>leukaemia</z:mpath>-associated MIRLET7 family </plain></SENT>
<SENT sid="4" pm="."><plain>A unique signature consisting of 10 microRNAs was closely associated with International Prognostic Scoring System (IPSS) risk category permitting discrimination between lower (Low/Intermediate-1) and higher risk (Intermediate-2/High) disease (P &lt; 0·01) </plain></SENT>
<SENT sid="5" pm="."><plain>Selective overexpression of MIR181 family members was detected in higher risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, indicating pathogenetic overlap with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Survival analysis of an independent cohort of 22 IPSS lower risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients revealed a median survival of 3·5 years in patients with high expression of MIR181 family compared to 9·3 years in patients with low MIR181 expression (P = 0·002) </plain></SENT>
<SENT sid="7" pm="."><plain>Our pilot study suggested that analysis of microRNA expression profile offers diagnostic utility, and provide pathogenetic and prognostic discrimination in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>